<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64507</article-id><article-id pub-id-type="doi">10.7554/eLife.64507</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-240743"><name><surname>Pérez-Vargas</surname><given-names>Jimena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215290"><name><surname>Teppa</surname><given-names>Elin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215289"><name><surname>Amirache</surname><given-names>Fouzia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241712"><name><surname>Boson</surname><given-names>Bertrand</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-240744"><name><surname>Pereira de Oliveira</surname><given-names>Rémi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215291"><name><surname>Combet</surname><given-names>Christophe</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7348-3520</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143887"><name><surname>Böckmann</surname><given-names>Anja</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8149-7941</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-99988"><name><surname>Fusil</surname><given-names>Floriane</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-243338"><name><surname>Freitas</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-36144"><name><surname>Carbone</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-99992"><name><surname>Cosset</surname><given-names>François-Loïc</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8842-3726</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>École normale supérieure de Lyon</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution content-type="dept">UMR 7238, Biologie Computationnelle et Quantitative</institution>, <institution>Sorbonne Université</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution>Centre International de Recherche en Infectiologie</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">U1052</institution>, <institution>Cancer Research Center of Lyon (CRCL)</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution content-type="dept">Molecular Microbiology and Structural Biochemistry</institution>, <institution>University of Lyon</institution>, <addr-line><named-content content-type="city">Lyon</named-content></addr-line>, <country>France</country></aff><aff id="aff6"><institution content-type="dept">UMR 7238, Biologie Computationnelle et Quantitative</institution>, <institution>Sorbonne Universités, UPMC Univ. Paris 06</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6168"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role>Reviewing editor</role><aff><institution>University College London</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>natalia.bezerra-de-freitas@ens-lyon.fr</email> (NF);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Alessandra.Carbone@lip6.fr</email> (AC);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>flcosset@ens-lyon.fr</email> (FC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64507</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Pérez-Vargas et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Pérez-Vargas et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64507-v1.pdf"/><abstract><p>Cell entry of enveloped viruses relies on the fusion between the viral and plasma or endosomal membranes, through a mechanism that is triggered by a cellular signal. Here we used a combination of computational and experimental approaches to unravel the main determinants of hepatitis B virus (HBV) membrane fusion process. We discovered that ERp57 is a host factor critically involved in triggering HBV fusion and infection. Then, through modelling approaches, we uncovered a putative allosteric cross-strand disulfide (CSD) bond in the HBV S glycoprotein and we demonstrate that its stabilization could prevent membrane fusion. Finally, we identified and characterized a potential fusion peptide in the preS1 domain of the HBV L glycoprotein. These results underscore a membrane fusion mechanism that could be triggered by ERp57, allowing a thiol/disulfide exchange reaction to occur and regulate isomerization of a critical CSD, which ultimately leads to the exposition of the fusion peptide.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>ANRS</institution></institution-wrap></funding-source><award-id>ECTZ160643</award-id><principal-award-recipient><name><surname>Cosset</surname><given-names>François-Loïc</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>ANR</institution></institution-wrap></funding-source><award-id>ANR-11-LABX-0048</award-id><principal-award-recipient><name><surname>Cosset</surname><given-names>François-Loïc</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were performed in accordance with the European Union guidelines for approval of the protocols by the local ethics committee (Authorization Agreement C2EA-15, &quot;Comité Rhône-Alpes d'Ethique pour l'Expérimentation Animale&quot;, Lyon, France - APAFIS#27316-2020060810332115 v4).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for figures 1-3, 5-7 and 9.</p></sec><supplementary-material><ext-link xlink:href="elife-64507-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>